ClinicalTrials.Veeva

Menu
E

Enverus Medical | Dr. Lorne E Albrecht & Associates

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LEO 43204
ESK-001
Guselkumab
JNJ-77242113

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

The purpose of the study is to see how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deu...

Active, not recruiting
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113 Matching Placebo
Locations recently updated

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to...

Enrolling
Psoriasis
Severe Psoriasis
Drug: Open-Label ESK-001
Drug: Blinded ESK-001

Trial sponsors

Janssen (J&J Innovative Medicine) logo
A
LEO Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems